IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 207 filers reported holding IMMUNOGEN INC in Q1 2018. The put-call ratio across all filers is 3.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $98,000 | -76.5% | 20,526 | -76.6% | 0.01% | -62.5% |
| Q1 2022 | $417,000 | -3.5% | 87,600 | +50.5% | 0.02% | -15.8% |
| Q4 2021 | $432,000 | +208.6% | 58,200 | +135.6% | 0.02% | +137.5% |
| Q3 2021 | $140,000 | -55.0% | 24,700 | -47.7% | 0.01% | -60.0% |
| Q2 2021 | $311,000 | -29.6% | 47,183 | -13.6% | 0.02% | -9.1% |
| Q1 2021 | $442,000 | +37.3% | 54,600 | +9.4% | 0.02% | +57.1% |
| Q4 2020 | $322,000 | +485.5% | 49,900 | +319.3% | 0.01% | +366.7% |
| Q2 2020 | $55,000 | -63.1% | 11,900 | -48.7% | 0.00% | -70.0% |
| Q4 2017 | $149,000 | – | 23,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |